AN OVERVIEW OF INCRETIN-BASED THERAPIES: PHARMACOLOGY AND FUTURE PERSPECTIVES
Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that is released upon nutrient ingestion stimulating insulin secretion, suppressing glucagon secretion, and suppressing appetite and food intake which contribute to glucose homeostasis. The incretin system is impaired during type 2 di...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Assiut University, Faculty of Pharmacy
2022-12-01
|
| Saila: | Bulletin of Pharmaceutical Sciences. Assiut University |
| Gaiak: | |
| Sarrera elektronikoa: | https://bpsa.journals.ekb.eg/article_271789_26f9de42af59a6d1fe9a68a3b3d98fbf.pdf |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|